* Equally contributing co-authorships

Huang Z, Hurley PJ, Simons BW, Marchionni L, Berman DM, Ross AE, Schaeffer EM.
Sox9 is required for prostate development and prostate cancer initiation.
Oncotarget. 2012 Jul;3(6):651-63.
Barbara Benassi, Richard Flavin, Luigi Marchionni, Silvio Zanata, Yunfeng Pan,Dipanjan Chowdhury, Marina Marani, Sabrina Strano, Paola Muti,Giovanni Blandino, and Massimo Loda
Myc is activated via USP2a-mediated modulation of microRNAs in prostate cancer
Cancer Discovery; Published OnlineFirst January 5, 2012;
Access raw data and Supplementary Material
Kornegoor R, Moelans CB, Verschuur-Maes AH, Hogenes MC, de Bruin PC, Oudejans JJ, Marchionni L, van Diest PJ
Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification
Breast Cancer Res Treat. 2012 Apr 13. [Epub ahead of print]
Huang TC, Sahasrabuddhe NA, Kim MS, Getnet D, Yang Y, Peterson JM, Ghosh B, Chaerkady R, Leach SD, Marchionni L, Wong GW, Pandey A.
Regulation of Lipid Metabolism by Dicer Revealed through SILAC Mice
J Proteome Res. 2012 Feb 28. [Epub ahead of print]. PMID: 22313051
Tyekucheva S, Marchionni L, Karchin R, Parmigiani G.
Integrating diverse genomic data using gene sets.
Genome Biol. 2011 Oct 21;12(10):R105. PubMed PMID: 22018358
Obtain the RTopper package from bioconductor
23. Cesselli D, Beltrami AP, D'Aurizio F, Marcon P, Bergamin N, Toffoletto B,Pandolfi M, Puppato E, Marino L, Signore S, Livi U, Verardo R, Piazza S, Marchionni L, Fiorini C, Schneider C, Hosoda T, Rota M, Kajstura J, Anversa P, Beltrami CA, Leri A.
Effects of age and heart failure on human cardiac stem cell function.
Am J Pathol. 2011 Jul;179(1):349-66. Epub 2011 May 19. PubMed PMID: 21703415.
22. Liu H, Kim Y, Sharkis S, Marchionni L, Jang YY.
In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins.
Sci Transl Med. 2011 May 11;3(82):82ra39. PubMed PMID: 21562231.
21. Ling S, Chang X, Schultz L, Lee TK, Chaux A, Marchionni L, Netto GJ, Sidransky D, Berman DM.
An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer. Cancer Res. 2011 Jun 1;71(11):3812-21. Epub 2011 Apr 21. PubMed PMID: 21512138; PubMed Central PMCID: PMC3107391.
20. Ross AE, Marchionni L, Phillips TM, Miller RM, Hurley PJ, Simons BW, Salmasi AH, Schaeffer AJ, Gearhart JP, Schaeffer EM.
Molecular effects of genistein on male urethral development.
J Urol. 2011 May;185(5):1894-8. Epub 2011 Mar 21. PubMed PMID: 21421236.
Access raw data and Supplementary Material
19. Ross AE, Marchionni L, Vuica-Ross M, Cheadle C, Fan J, Berman DM, Schaeffer EM.
Gene expression pathways of high grade localized prostate cancer
Prostate. 2011 Feb 25. doi: 10.1002/pros.21373. [Epub ahead of print] PubMed PMID: 21360566.
Access raw data and Supplementary Material
18. Ross AE, Emadi A, Marchionni L, Hurley PJ, Simons BW, Schaeffer EM, Vuica-Ross
M. Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity.
BJU Int. 2011 Aug;108(3):447-54. doi:10.1111/j.1464-410X.2010.09907.x. Epub 2010 Dec 22. PubMed PMID: 21176082.
17. Schreck KC, Taylor P, Marchionni L, Gopalakrishnan V, Bar EE, Gaiano N, Eberhart CG.
The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance.
Clin Cancer Res. 2010 Dec 15;16(24):6060-70. PubMed PMID: 21169257; PubMed Central PMCID: PMC3059501.
16. Noonan K, Marchionni L, Anderson J, Pardoll D, Roodman GD, Borrello I.
A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma.
Blood. 2010 Nov 4;116(18):3554-63. Epub 2010 Jul 27. PubMed PMID: 20664052.
15. Kachhap SK, Rosmus N, Collis SJ, Kortenhorst MS, Wissing MD, Hedayati M,Shabbeer S, Mendonca J, Deangelis J, Marchionni L, Lin J, Höti N, Nortier JW, DeWeese TL, Hammers H, Carducci MA.
Downregulation of homologous recombinationDNA repair genes by HDAC inhibition in prostate cancer is mediated through theE2F1 transcription factor.
PLoS One. 2010 Jun 18;5(6):e11208. PubMed PMID:20585447; PubMed Central PMCID: PMC2887841.
14. Seeber LM, Zweemer RP, Marchionni L, Massuger LF, Smit VT, van Baal WM, Verheijen RH, van Diest PJ.
Methylation profiles of endometrioid and serousendometrial cancers.
Endocr Relat Cancer. 2010 Jun 25;17(3):663-73. Print 2010Sep. PubMed PMID: 20488783.
13. Xue Lin, Bahman Asfari, Luigi Marchionni, Leslie Cope, Giovanni Parmigiani, Daniel Naiman and Donald Geman
The Ordering of Expression Among a Few Genes Can Provide Simple Cancer Biomarkers and Signal BRCA1 Mutations
2009 Aug 20;10(1):256. [Epub ahead of print]
12. He X, Marchionni L, Hansel DE, Yu W, Sood A, Yang J, Parmigiani G, Matsui W, Berman DM
Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma
Stem Cells 2009 Jul 4;27(7):1487-95. [PubMed - in process]
Access raw data and Supplementary Material
11. Daniel VC*, Marchionni L*, Hierman JS*, Rhodes JT, Devereux WL, Rudin CM, Yung R, Parmigani G, Dorsch M, Peacock CD, Watkins DN.
A Primary Xenograft Model of Small Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In-Vitro.
Cancer Research, 2009 Apr 15;69(8):3364-73. [Epub 2009 Apr 7]
Access raw data and Supplementary Material
10. Edward M Schaeffer*, Luigi Marchionni*, Zhenhua Huang, Brian Simons, Amanda Blackman, Wayne Yu, Giovanni Parmigiani, and David M Berman
Androgen induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer
Oncogene 2008 Dec 4;27(57):7180-91. [Epub 2008 Sep 15.]
Access raw data and Supplementary Material
9. Marchionni L, Wilson RF, Marinopoulos SS, Wolff AC, Parmigiani G, Bass EB, Goodman SN.
Systematic review: gene expression profiling assays in early-stage breast cancer.
Ann Intern Med 2008 Mar 4;148(5):358-69. [Epub 2008 Feb 4]
8. Marchionni L, Wilson RF, Wolff AC, Marinopoulos S, Parmigiani G, Bass EB, Goodman SN.
Impact of gene expression profiling tests on breast cancer outcomes
Agency for Healthcare Research and Quality (AHRQ),
Evid Rep Technol Assess. 2007 Dec;(160):1-105
7. The FANTOM Consortium; RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group)
The transcriptional landscape of the mammalian genome
Science 2005; 309(5740): 1559-63
6. Dalla E, Mignone F, Verardo R, Marchionni L, Marzinotto S, Lazareviç D, Reid JF, Marzio R, Klariç E, Licastro D, Marcuzzi G, Gambetta R, Pierotti MA, Pesole G and Schneider C
Discovery of 342 putative new genes from the analysis of 5'-end-sequenced full-length-enriched cDNA Human Transcripts
Genomics 2005; 85(6): 739-51
5. De Cecco L*, Marchionni L*, Gariboldi M, Reid JF, Lagonigro M, Caramuta S, Ferrario C, Bussani E, Mezzanzanica D, Turatti F, Delia D, Daidone MG, Oggionni M, Bertuletti N, Ditto A, Raspagliesi F, Pilotti S, Pierotti MA, Canevari S and Schneider C
Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2
Oncogene 2004; 23(49): 8171-83
4. Monte M, Benetti R, Collavin L, Marchionni L, Del Sal G, Schneider C
hGTSE-1 expression stimulates cytoplasmic localization of p53
J Biol Chem, 2004; 279: 11744-52
3. Dalla E, Verardo R, Lazareviç D, Marchionni L, Reid JF, Bahar N, Klariç E, Marcuzzi G, Marzio R, Belgrano A, Licastro D, Schneider C
Human full-length cDNAs collection: towards a better comprehension of the human transcriptome
C R Biol 2003; 326: 967-70
2. The RIKEN Genome Exploration Group Phase II Team and the FANTOM2 consortium
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs
Nature 2002; 420: 563-73
1. The RIKEN Genome Exploration Group Phase II Team and the FANTOM consortium
Functional annotation of a full-length mouse cDNA collection
Nature 2001; 409: 685-690
* Equally contributing co-authorships